Does Rallies show 13F holders for SNOA?

Yes. Rallies tracks hedge fund and 13F ownership data for SNOA, including fund names, share counts, latest tracked quarter, and position changes when available.

Is SNOA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SNOA. It does not provide personalized investment advice.

SNOA (Sonoma Pharmaceuticals, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Sonoma Pharmaceuticals, Inc. Common Stock (SNOA) is a publicly traded Healthcare sector company. As of May 21, 2026, SNOA trades at $1.12 with a market cap of $3.58M and a P/E ratio of -0.38. SNOA moved +4.46% today. Year to date, SNOA is -71.31%; over the trailing twelve months it is -67.48%. Its 52-week range spans $0.85 to $6.92. Rallies surfaces SNOA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns SNOA stock?

Hedge funds tracked by Rallies that own SNOA include Citadel Advisors and Two Sigma. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Sonoma Pharmaceuticals, Inc. Common Stock.

SNOA Key Metrics

Key financial metrics for SNOA
Metric	Value
Price	$1.12
Market Cap	$3.58M
P/E Ratio	-0.38
EPS	$-2.79
Dividend Yield	0.00%
52-Week High	$6.92
52-Week Low	$0.85
Volume	4.83K
Avg Volume	0
Revenue (TTM)	$14.29M
Net Income	$-2.91M
Gross Margin	38.25%

Top Hedge Funds Holding SNOA

Citadel Advisors holds 195.16K shares of SNOA, changed +67.12% as of Jun 30, 2024.
Two Sigma holds 15.32K shares of SNOA, changed +13.75% as of Jun 30, 2024.

Latest SNOA News

Sonoma Pharmaceuticals Launches $4M Stock and Warrant Offering with 15% Over-Allotment Option — Apr 24, 2026
Sonoma Pharmaceuticals Launches Advanced Burn Relief Hydrogel in CVS and Walmart — Mar 24, 2026
Sonoma Pharmaceuticals Launches Exclusive Aquanil AD Dermatology Line with Person & Covey — Mar 18, 2026

SNOA Analyst Consensus

SNOA analyst coverage data. Average price target: $0.00.

Common questions about SNOA

Who owns SNOA stock?: Hedge funds tracked by Rallies that own SNOA include Citadel Advisors and Two Sigma. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Sonoma Pharmaceuticals, Inc. Common Stock.
Does Rallies show 13F holders for SNOA?: Yes. Rallies tracks hedge fund and 13F ownership data for SNOA, including fund names, share counts, latest tracked quarter, and position changes when available.
Is SNOA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SNOA. It does not provide personalized investment advice.